Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.22 USD | -0.97% |
|
-5.57% | +0.76% |
05-12 | UBS Adjusts Price Target on Pediatrix Medical Group to $16 From $18.50, Maintains Neutral Rating | MT |
05-06 | Pediatrix Medical Q1 Adjusted Earnings Increase, Net Revenue Falls | MT |
Capitalization | 1.11B 966M 910M 826M 1.53B 96.42B 1.72B 10.77B 4.12B 44.17B 4.18B 4.09B 162B | P/E ratio 2025 * |
9.35x | P/E ratio 2026 * | 8.77x |
---|---|---|---|---|---|
Enterprise value | 1.34B 1.16B 1.1B 996M 1.84B 116B 2.08B 12.98B 4.97B 53.24B 5.04B 4.93B 196B | EV / Sales 2025 * |
0.72x | EV / Sales 2026 * | 0.63x |
Free-Float |
98.33% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Pediatrix Medical Group, Inc.
More recommendations
More press releases
1 day | -0.97% | ||
1 week | -5.57% | ||
Current month | -6.57% | ||
1 month | -12.85% | ||
3 months | -6.97% | ||
6 months | -6.17% | ||
Current year | +0.76% |
1 week | 13.12 | ![]() | 14.2 |
1 month | 13.12 | ![]() | 14.44 |
Current year | 11.94 | ![]() | 17.67 |
1 year | 6.62 | ![]() | 17.67 |
3 years | 6.62 | ![]() | 23.95 |
5 years | 6.62 | ![]() | 35.68 |
10 years | 6.62 | ![]() | 86.09 |
Manager | Title | Age | Since |
---|---|---|---|
Mark Ordan
CEO | Chief Executive Officer | 66 | 2025-01-12 |
Kasandra Rossi
DFI | Director of Finance/CFO | 52 | 2024-09-30 |
Reese Clark
CTO | Chief Tech/Sci/R&D Officer | - | - |
Director | Title | Age | Since |
---|---|---|---|
Michael Rucker
BRD | Director/Board Member | 55 | 2019-05-15 |
Thomas McEachin
BRD | Director/Board Member | 72 | 2020-07-11 |
Guy Sansone
CHM | Chairman | 60 | 2020-07-11 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-0.97% | -5.57% | +65.25% | -30.16% | 1.11B | ||
+0.17% | +1.70% | +11.38% | +117.12% | 90.82B | ||
-0.40% | -1.32% | +8.47% | -26.91% | 84.21B | ||
+0.91% | -4.52% | +49.66% | +51.17% | 27.28B | ||
+1.22% | -0.64% | -13.26% | +24.90% | 23.02B | ||
+0.19% | +0.29% | +27.59% | +14.09% | 21.92B | ||
-0.19% | -0.43% | +29.12% | +36.00% | 20.03B | ||
+0.85% | -6.80% | +31.48% | +2.60% | 15.73B | ||
+0.26% | +2.21% | +25.15% | +222.17% | 15.61B | ||
-1.33% | -0.85% | +32.07% | +14.97% | 13.94B | ||
Average | +0.07% | -1.71% | +26.69% | +42.59% | 31.37B | |
Weighted average by Cap. | +0.10% | -0.69% | +17.19% | +47.99% |
2025 * | 2026 * | |
---|---|---|
Net sales | 1.87B 1.63B 1.53B 1.39B 2.57B 162B 2.9B 18.13B 6.94B 74.35B 7.03B 6.88B 273B | 1.93B 1.68B 1.58B 1.44B 2.66B 168B 2.99B 18.72B 7.16B 76.77B 7.26B 7.11B 282B |
Net income | 121M 105M 99.13M 90.07M 167M 10.51B 188M 1.17B 449M 4.81B 455M 446M 17.7B | 127M 110M 104M 94.48M 175M 11.02B 197M 1.23B 471M 5.05B 478M 467M 18.56B |
Net Debt | 229M 198M 187M 170M 314M 19.8B 354M 2.21B 846M 9.07B 858M 840M 33.34B | 113M 98.06M 92.37M 83.93M 155M 9.79B 175M 1.09B 419M 4.49B 424M 415M 16.49B |
More financial data
* Estimated data
Employees
4,120
Calendar
Date | Price | Change | Volume |
---|---|---|---|
25-06-20 | 13.22 $ | -0.97% | 1,014,841 |
25-06-18 | 13.35 $ | -0.45% | 594,733 |
25-06-17 | 13.41 $ | -2.97% | 709,681 |
25-06-16 | 13.82 $ | -1.29% | 758,050 |
25-06-13 | 14.00 $ | -1.75% | 671,140 |
Delayed Quote Nyse, June 20, 2025 at 04:00 pm
More quotesSell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
13.22USD
Average target price
17.14USD
Spread / Average Target
+29.67%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MD Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition